Search Results Search Sort by RelevanceMost Recent State of the Art and Science Dec 2016 Locating Risk in the Adolescent Brain: Ethical Challenges in the Use of Biomarkers for Adolescent Health and Social Policy Suparna Choudhury, PhD and Sheehan Moore Neurobiological markers raise complex questions about what it means to be “at risk.” AMA J Ethics. 2016;18(12):1199-1206. doi: 10.1001/journalofethics.2016.18.12.stas1-1612. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 1 Stephen L. Brotherton, MD Virtual Mentor. 2004;6(7):298-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 2 Norman C. Fost, MD, MPH Virtual Mentor. 2004;6(7):300-301. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 3 Gary A. Green, MD Virtual Mentor. 2004;6(7):301-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Policy Forum Dec 2016 Promoting Access to School-Based Services for Children’s Mental Health MaryKatherine Brueck Disparities in children’s mental health care could be addressed through expansion of school-based programs via passage of the Mental Health in Schools Act. AMA J Ethics. 2016;18(12):1218-1224. doi: 10.1001/journalofethics.2016.18.12.pfor1-1612. In the Literature Jun 2007 Cosmetic Psychopharmacology and the Goals of Medicine Erica K. Rangel A look at Pamela Bjorkland’s critique of the use of psychoactive drugs to improve mood, a practice known as cosmetic psychopharmacology. Virtual Mentor. 2007;9(6):428-432. doi: 10.1001/virtualmentor.2007.9.6.jdsc1-0706.
State of the Art and Science Dec 2016 Locating Risk in the Adolescent Brain: Ethical Challenges in the Use of Biomarkers for Adolescent Health and Social Policy Suparna Choudhury, PhD and Sheehan Moore Neurobiological markers raise complex questions about what it means to be “at risk.” AMA J Ethics. 2016;18(12):1199-1206. doi: 10.1001/journalofethics.2016.18.12.stas1-1612.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 1 Stephen L. Brotherton, MD Virtual Mentor. 2004;6(7):298-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 2 Norman C. Fost, MD, MPH Virtual Mentor. 2004;6(7):300-301. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 3 Gary A. Green, MD Virtual Mentor. 2004;6(7):301-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Policy Forum Dec 2016 Promoting Access to School-Based Services for Children’s Mental Health MaryKatherine Brueck Disparities in children’s mental health care could be addressed through expansion of school-based programs via passage of the Mental Health in Schools Act. AMA J Ethics. 2016;18(12):1218-1224. doi: 10.1001/journalofethics.2016.18.12.pfor1-1612.
In the Literature Jun 2007 Cosmetic Psychopharmacology and the Goals of Medicine Erica K. Rangel A look at Pamela Bjorkland’s critique of the use of psychoactive drugs to improve mood, a practice known as cosmetic psychopharmacology. Virtual Mentor. 2007;9(6):428-432. doi: 10.1001/virtualmentor.2007.9.6.jdsc1-0706.